Answers are grounded in this paper and cite their sources.
Review highlights PPAR activation in vascular cells, suggesting potential therapeutic mechanisms to reduce atherogenesis and cardiovascular risk.
Peroxisome proliferator-activated receptors (PPARs) are nuclear transcription factors that regulate gene expression in response to activation by specific ligands including insulin sensitizing thiazolidinedione and lipid-lowering fibrates. Recent work has identified PPARalpha and PPARgamma expression in vascular cells and established a role for these receptors in the regulation of genes relevant to atherogenesis. The following review will focus on the role of PPAR activation in the vasculature and discuss the potential clinical implications of these findings.
No takes yet. Share an insight, caveat, or question.
Marx et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: